When Practitioners Harm More Than Heal

Posted By


Missing The Target: When Practitioners Harm More Than Heal” is the title of a two-day conference in Washington this week (June 14-15) hosted by PharmedOut.org at Georgetown.  This is their third annual conference – this one focusing on how patient harms may result from industry promotions.

The full agenda and abstracts are now available online.

Some of the speakers:

  • Rita Redberg, M.D., M.Sc., Archives of Internal Medicine Editor-in-Chief; professor of medicine, University of California, San Francisco
  • Carl Elliott, M.D. Ph.D., author, White Coat, Black Hat; professor, University of Minnesota’s Center for Bioethics
  • Kay Dickersin, Ph.D., director, Center for Clinical Trials, Johns Hopkins Center for Global Health
  • Julie Taitsman, M.D., J.D., chief medical officer, Office of the Inspector General, U.S. Department of Health and Human Services
  • Sharon Treat, J.D., executive director, National Legislative Association on Prescription Drug Prices
  • Thomas M. Burton, Pulitzer Prize winning-journalist, The Wall Street Journal
  • Shannon Brownlee, M.S., author, Overtreated; acting director, New America Foundation Health Policy Program
  • Susan Wood, PhD, George Washington University
  • Sean Flynn, JD, American University
  • Joel Lexchin, MD, York University
  • Barbara Mintzes, Therapeutics Initiative

Some of the topics:

  •  Marketing of antipsychotic medications and other drugs
  •  Potential health risks of CT scans and other medical devices
  • Legislative and regulatory updates and solutions
  •  The role of industry, media, and payers in informing and protecting patients
  • The Underuse of Classic Drugs
  • Are Medical Devices and Drugs Adequately Regulated?
  • Protecting Patients in Industry-Funded Trials
  • Pharmaceutical Marketing and Adverse Health Outcomes

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.